Cargando…

Visual Outcomes after Implantation of Lucidis EDOF IOL

PURPOSE: To evaluate the visual performance and clinical outcomes after implantation of Lucidis EDOF IOL following cataract surgery. DESIGN: In this retrospective study, medical records from all enrolled patients were analyzed, and the following information was extracted retrospectively over 3 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabinovich, Mark, Ceresara, Gaia, Aramburu del Boz, Ana, Al Khatib, Danial, Crespe, Marie, Bovet, Jerome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167139/
https://www.ncbi.nlm.nih.gov/pubmed/35669466
http://dx.doi.org/10.1155/2022/5100861
_version_ 1784720766259953664
author Rabinovich, Mark
Ceresara, Gaia
Aramburu del Boz, Ana
Al Khatib, Danial
Crespe, Marie
Bovet, Jerome
author_facet Rabinovich, Mark
Ceresara, Gaia
Aramburu del Boz, Ana
Al Khatib, Danial
Crespe, Marie
Bovet, Jerome
author_sort Rabinovich, Mark
collection PubMed
description PURPOSE: To evaluate the visual performance and clinical outcomes after implantation of Lucidis EDOF IOL following cataract surgery. DESIGN: In this retrospective study, medical records from all enrolled patients were analyzed, and the following information was extracted retrospectively over 3 months following surgery. MATERIALS AND METHODS: We reviewed retrospectively 181 eyes of 98 patients, who underwent cataract surgery with Lucidis extended depth of focus IOL. RESULTS: 44 patients were males (45%) and 54 were females (55%). The average age of the study population was 68 ± 11 years. The mean preoperative BCVA (logMAR) was 0.19 ± 0.18. The mean root mean square (RMS) high order aberration (HOA) was 0.18 ± 0.1. Monocular BCVA results were 0.02 ± 0.04 (logMAR) and 0.028 ± 0.04 (logMAR) 1 month and 3 months postoperatively, respectively. Between the baseline and 1-month measures, monocular distance BCVA improved by an average of 0.17 ± 0.14 logMAR (p = 0.0001). Between the baseline and 3-month postoperative measures, monocular distance BCVA improved by an average of 0.16 ± 0.13 logMAR (p = 0.0001). Monocular UDVA 1 and 3 months postoperatively was 0.08 ± 0.1 logMAR and 0.067 ± 0.08 logMAR, respectively. 1-Month postoperative binocular UDVA was 0.036 ± 0.05 logMAR, binocular UIVA was 0.1 ± 0.08 logMAR, and binocular UNVA was 0.12 ± 0.14 logMAR. 3-Month postoperative binocular UDVA was 0.038 ± 0.05 logMAR, binocular UIVA was 0.09 ± 0.1 logMAR, and binocular UNVA was 0.16 ± 0.14 logMAR. CONCLUSIONS: Lucidis EDOF IOL achieves good visual performances in all distances.
format Online
Article
Text
id pubmed-9167139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-91671392022-06-05 Visual Outcomes after Implantation of Lucidis EDOF IOL Rabinovich, Mark Ceresara, Gaia Aramburu del Boz, Ana Al Khatib, Danial Crespe, Marie Bovet, Jerome J Ophthalmol Research Article PURPOSE: To evaluate the visual performance and clinical outcomes after implantation of Lucidis EDOF IOL following cataract surgery. DESIGN: In this retrospective study, medical records from all enrolled patients were analyzed, and the following information was extracted retrospectively over 3 months following surgery. MATERIALS AND METHODS: We reviewed retrospectively 181 eyes of 98 patients, who underwent cataract surgery with Lucidis extended depth of focus IOL. RESULTS: 44 patients were males (45%) and 54 were females (55%). The average age of the study population was 68 ± 11 years. The mean preoperative BCVA (logMAR) was 0.19 ± 0.18. The mean root mean square (RMS) high order aberration (HOA) was 0.18 ± 0.1. Monocular BCVA results were 0.02 ± 0.04 (logMAR) and 0.028 ± 0.04 (logMAR) 1 month and 3 months postoperatively, respectively. Between the baseline and 1-month measures, monocular distance BCVA improved by an average of 0.17 ± 0.14 logMAR (p = 0.0001). Between the baseline and 3-month postoperative measures, monocular distance BCVA improved by an average of 0.16 ± 0.13 logMAR (p = 0.0001). Monocular UDVA 1 and 3 months postoperatively was 0.08 ± 0.1 logMAR and 0.067 ± 0.08 logMAR, respectively. 1-Month postoperative binocular UDVA was 0.036 ± 0.05 logMAR, binocular UIVA was 0.1 ± 0.08 logMAR, and binocular UNVA was 0.12 ± 0.14 logMAR. 3-Month postoperative binocular UDVA was 0.038 ± 0.05 logMAR, binocular UIVA was 0.09 ± 0.1 logMAR, and binocular UNVA was 0.16 ± 0.14 logMAR. CONCLUSIONS: Lucidis EDOF IOL achieves good visual performances in all distances. Hindawi 2022-05-28 /pmc/articles/PMC9167139/ /pubmed/35669466 http://dx.doi.org/10.1155/2022/5100861 Text en Copyright © 2022 Mark Rabinovich et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Rabinovich, Mark
Ceresara, Gaia
Aramburu del Boz, Ana
Al Khatib, Danial
Crespe, Marie
Bovet, Jerome
Visual Outcomes after Implantation of Lucidis EDOF IOL
title Visual Outcomes after Implantation of Lucidis EDOF IOL
title_full Visual Outcomes after Implantation of Lucidis EDOF IOL
title_fullStr Visual Outcomes after Implantation of Lucidis EDOF IOL
title_full_unstemmed Visual Outcomes after Implantation of Lucidis EDOF IOL
title_short Visual Outcomes after Implantation of Lucidis EDOF IOL
title_sort visual outcomes after implantation of lucidis edof iol
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167139/
https://www.ncbi.nlm.nih.gov/pubmed/35669466
http://dx.doi.org/10.1155/2022/5100861
work_keys_str_mv AT rabinovichmark visualoutcomesafterimplantationoflucidisedofiol
AT ceresaragaia visualoutcomesafterimplantationoflucidisedofiol
AT aramburudelbozana visualoutcomesafterimplantationoflucidisedofiol
AT alkhatibdanial visualoutcomesafterimplantationoflucidisedofiol
AT crespemarie visualoutcomesafterimplantationoflucidisedofiol
AT bovetjerome visualoutcomesafterimplantationoflucidisedofiol